Ordena

Cercar

Barra de cerca
04/04/2023 ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I, Torres, A, Nagavci, B, Aliberti, S, Antonelli, M, Bassetti, M, Bos, L, Chalmers, J, Derde, L, de Waele, J, Garnacho-Montero, J, Kollef, M, Luna, C, Menendez, R, Niederman, M, Ponomarev, D, Restrepo, M, Rigau, D, Schultz, M, Weiss, E, Welte, T, Wunderink, R. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. INTENSIVE CARE MEDICINE. 2023; 49(6)DOI:10.1007/s00134-023-07033-8. PMID:37012484. IF:29.600(Q1/1D).
03/04/2023 Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain
de Frutos F., Ochoa J.P., Gómez-González C., Reyes-Leiva D., Aróstegui J.I., Casasnovas C., Barriales-Villa R., Sevilla T., Gonzalez-Lopez E., Ramil E., Galan L., González-Costello J., García-Álvarez A., Rojas-Garcia R., Espinosa M.A., Garcia-Pavia P.. Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. 2023; 30(2)DOI:10.1080/13506129.2022.2142110. PMID:36343383. IF:5.200(Q1/1D).
03/04/2023 ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I, Torres, A, Nagavci, B, Aliberti, S, Antonelli, M, Bassetti, M, Bos, L, Chalmers, J, Derde, L, de Waele, J, Garnacho-Montero, J, Kollef, M, Luna, C, Menendez, R, Niederman, M, Ponomarev, D, Restrepo, M, Rigau, D, Schultz, M, Weiss, E, Welte, T, Wunderink, R. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. EUROPEAN RESPIRATORY JOURNAL. 2023; 61(4)DOI:10.1183/13993003.00735-2022. PMID:37012080. IF:17.000(Q1/1D).
03/04/2023 Critical Commentary on the paper: Compatibility of prolonged infusion antibiotics during Y-site administration with parenteral nutrition
De Pourcq J.T., Riera P.. Critical Commentary on the paper: Compatibility of prolonged infusion antibiotics during Y-site administration with parenteral nutrition. Nursing in Critical Care. 2023; 28(6)DOI:10.1111/nicc.12910. PMID:37232328. IF:3.000(Q1/1D).